Long-term benefits and risks of drug-eluting compared to bare-metal stents in patients with versus without chronic kidney disease

Maria Wanitschek; Matthias Pfisterer; Anders Hvelplund; Stefano De Servi; Osmund Bertel; Raban Jeger; Peter Rickenbacher; Allan Iversen; Jan Skov Jensen; Soeren Galatius; Christoph Kaiser; Hannes Alber; BASKET-PROVE Investigators

doi:10.1016/j.ijcard.2013.01.257

Long-term benefits and risks of drug-eluting compared to bare-metal stents in patients with versus without chronic kidney disease

Maria Wanitschek
, Matthias Pfisterer
, Anders Hvelplund
, Stefano De Servi
, Osmund Bertel
, Raban Jeger
, Peter Rickenbacher
, Allan Iversen
, Jan Skov Jensen
, Soeren Galatius
, Christoph Kaiser
, Hannes Alber
, BASKET-PROVE Investigators

15 Citationer (Scopus)

Abstract

AIMS: Chronic kidney disease (CKD) is associated with worse outcomes in patients with coronary artery disease (CAD). How CKD influences the benefit-risk balance of drug-eluting stents (DES) versus bare-metal stents (BMS) is less known. METHODS AND RESULTS: In the multicentre BASKET-PROVE trial, 2314 patients in need of large coronary stenting (≥3.0mm) were randomised 2:1 to DES or BMS. In an a priori planned secondary analysis, outcomes were evaluated according to renal function defined by estimated glomerular filtration rates (eGFR; normal: eGFR≥60ml/min/1.73m(2); CKD: eGFR

Originalsprog	Engelsk
Tidsskrift	International Journal of Cardiology Research
Vol/bind	20
Udgave nummer	6
Sider (fra-til)	2381-8
DOI	https://doi.org/10.1016/j.ijcard.2013.01.257
Status	Udgivet - 3 okt. 2013

Adgang til dokumentet

10.1016/j.ijcard.2013.01.257

Citationsformater

Wanitschek, M., Pfisterer, M., Hvelplund, A., De Servi, S., Bertel, O., Jeger, R., Rickenbacher, P., Iversen, A., Jensen, J. S., Galatius, S., Kaiser, C., Alber, H., & BASKET-PROVE Investigators (2013). Long-term benefits and risks of drug-eluting compared to bare-metal stents in patients with versus without chronic kidney disease. International Journal of Cardiology Research, 20(6), 2381-8. https://doi.org/10.1016/j.ijcard.2013.01.257

Long-term benefits and risks of drug-eluting compared to bare-metal stents in patients with versus without chronic kidney disease. / Wanitschek, Maria; Pfisterer, Matthias; Hvelplund, Anders et al.
I: International Journal of Cardiology Research, Bind 20, Nr. 6, 03.10.2013, s. 2381-8.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

Wanitschek, M, Pfisterer, M, Hvelplund, A, De Servi, S, Bertel, O, Jeger, R, Rickenbacher, P, Iversen, A, Jensen, JS, Galatius, S, Kaiser, C, Alber, H & BASKET-PROVE Investigators 2013, 'Long-term benefits and risks of drug-eluting compared to bare-metal stents in patients with versus without chronic kidney disease', International Journal of Cardiology Research, bind 20, nr. 6, s. 2381-8. https://doi.org/10.1016/j.ijcard.2013.01.257

@article{de841e1882f64277a0cf0044ecf1a64a,

title = "Long-term benefits and risks of drug-eluting compared to bare-metal stents in patients with versus without chronic kidney disease",

abstract = "AIMS: Chronic kidney disease (CKD) is associated with worse outcomes in patients with coronary artery disease (CAD). How CKD influences the benefit-risk balance of drug-eluting stents (DES) versus bare-metal stents (BMS) is less known. METHODS AND RESULTS: In the multicentre BASKET-PROVE trial, 2314 patients in need of large coronary stenting (≥3.0mm) were randomised 2:1 to DES or BMS. In an a priori planned secondary analysis, outcomes were evaluated according to renal function defined by estimated glomerular filtration rates (eGFR; normal: eGFR≥60ml/min/1.73m(2); CKD: eGFR",

author = "Maria Wanitschek and Matthias Pfisterer and Anders Hvelplund and \{De Servi\}, Stefano and Osmund Bertel and Raban Jeger and Peter Rickenbacher and Allan Iversen and Jensen, \{Jan Skov\} and Soeren Galatius and Christoph Kaiser and Hannes Alber and \{BASKET-PROVE Investigators\}",

year = "2013",

month = oct,

day = "3",

doi = "10.1016/j.ijcard.2013.01.257",

language = "English",

volume = "20",

pages = "2381--8",

journal = "International Journal of Cardiology Research",

publisher = "Bioinfo Publications",

number = "6",

}

TY - JOUR

T1 - Long-term benefits and risks of drug-eluting compared to bare-metal stents in patients with versus without chronic kidney disease

AU - Wanitschek, Maria

AU - Pfisterer, Matthias

AU - Hvelplund, Anders

AU - De Servi, Stefano

AU - Bertel, Osmund

AU - Jeger, Raban

AU - Rickenbacher, Peter

AU - Iversen, Allan

AU - Jensen, Jan Skov

AU - Galatius, Soeren

AU - Kaiser, Christoph

AU - Alber, Hannes

AU - BASKET-PROVE Investigators

PY - 2013/10/3

Y1 - 2013/10/3

N2 - AIMS: Chronic kidney disease (CKD) is associated with worse outcomes in patients with coronary artery disease (CAD). How CKD influences the benefit-risk balance of drug-eluting stents (DES) versus bare-metal stents (BMS) is less known. METHODS AND RESULTS: In the multicentre BASKET-PROVE trial, 2314 patients in need of large coronary stenting (≥3.0mm) were randomised 2:1 to DES or BMS. In an a priori planned secondary analysis, outcomes were evaluated according to renal function defined by estimated glomerular filtration rates (eGFR; normal: eGFR≥60ml/min/1.73m(2); CKD: eGFR

AB - AIMS: Chronic kidney disease (CKD) is associated with worse outcomes in patients with coronary artery disease (CAD). How CKD influences the benefit-risk balance of drug-eluting stents (DES) versus bare-metal stents (BMS) is less known. METHODS AND RESULTS: In the multicentre BASKET-PROVE trial, 2314 patients in need of large coronary stenting (≥3.0mm) were randomised 2:1 to DES or BMS. In an a priori planned secondary analysis, outcomes were evaluated according to renal function defined by estimated glomerular filtration rates (eGFR; normal: eGFR≥60ml/min/1.73m(2); CKD: eGFR

U2 - 10.1016/j.ijcard.2013.01.257

DO - 10.1016/j.ijcard.2013.01.257

M3 - Journal article

C2 - 23453439

VL - 20

SP - 2381

EP - 2388

JO - International Journal of Cardiology Research

JF - International Journal of Cardiology Research

IS - 6

ER -

Long-term benefits and risks of drug-eluting compared to bare-metal stents in patients with versus without chronic kidney disease

Abstract

Adgang til dokumentet

Fingeraftryk

Citationsformater